Global Pharmaceuticals & Biotech Big Green Snowflakes

Advantis

Market Cap: US$878.0

Develops and markets products focusing on medical cannabis, research, and pharmaceutical sectors.

Flowr

Market Cap: US$426.0

The Flowr Corporation cultivates, produces, and sells cannabis in Canada.

Applied Biosciences

Market Cap: US$2.1k

Focuses on the development and commercialization of synthetic cannabinoid therapeutics/biopharmaceuticals that target the endocannabinoid system to treat a range of diseases across various therapeutic areas.

YourWay Cannabis Brands

Market Cap: US$272.0

Through its subsidiaries, engages in the manufacture, possession, use, sale, and distribution of cannabis in the recreational and medicinal cannabis market in the United States.

Sproutly Canada

Market Cap: US$379.0

Produces and supplies water-soluble cannabis solutions and bio-natural oils to beverage and consumables markets in Canada.

Winston Pharmaceuticals

Market Cap: US$7.7k

A pharmaceutical company, discovers, develops, and commercializes therapeutics for pain management.

Tian'an Pharmaceutical

Market Cap: US$196.1k

Develops, manufactures, and sells traditional Chinese herbal medicines, including pallets, hard capsules, and soft ointments for the treatment and prevention of diseases in China.

Black Bird Biotech

Market Cap: US$3.7k

Black Bird Biotech Inc. provides various biotech products.

Han.biomedical

Market Cap: NT$948.8m

Develops structured biomaterials for tissue regeneration in Taiwan.

Aeolus Pharmaceuticals

Market Cap: US$15.2k

A biopharmaceutical company, develops a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious, and central nervous system diseases in the United States.

CanaQuest Medical

Market Cap: US$298.9k

Develops health products and pharmaceuticals that utilize hemps, cannabis, and algae oils.

Progen

Market Cap: ₩115.3b

A biotechnology company, engages in platform-based drug discovery and development activities.

Baskhanbio Pharma

Market Cap: ₩35.8b

Provides pain medicines before and after surgery, and medical devices for surgical process in South Korea.

Breeze Holdings Acquisition

Market Cap: US$959.9m

Operates as a clinical-stage biopharmaceutical company focuses on cancer prevention medical diagnostics and the development of exosome-based therapeutics with the potential to transform the treatment of a diseases with unmet medical need.

MedMen Enterprises

Market Cap: US$1.6k

Operates as a cannabis retailer in the United States.

Grapefruit USA

Market Cap: US$996.0k

Operates as a manufacturer and distributor of cannabis products in California.

Cardiogeni

Market Cap: UK£8.0m

A clinical stage biotechnology company, develops heart failure medicines.

Cereno Scientific

Market Cap: SEK 2.8b

A clinical stage biotechnology company, develops therapeutics to treat cardiovascular and pulmonary diseases in Sweden and internationally.

NanoLogix

Market Cap: US$162.0

A biotechnology company, provides live cell and rapid diagnostics test kits that detects viable bacteria and other microorganisms.

Xebra Brands

Market Cap: CA$42.1k

Engages in the cultivation, processing, manufacture, design, and delivery of cannabis products in Canada, Europe, and Mexico.

Oncology Pharma

Market Cap: US$7.7k

An oncology company, develops, manufactures, and commercializes therapeutics.

Bioasis Technologies

Market Cap: US$79.0

A development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders.

Zhengduozhe Technology

Market Cap: US$84.1k

Zhengduozhe Technology, Inc, doing business as DAKOTA Life Sciences, operates as a biopharmaceutical company that focuses on the acquisition, development, and commercialization of pharmaceuticals designed to prevent and treat serious conditions arising in hospital and community settings.

Biostar Pharmaceuticals

Market Cap: US$2.0

Develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the People’s Republic of China.

OncoVista Innovative Therapies

Market Cap: US$2.4k

A biopharmaceutical company, develops targeted anticancer therapies by utilizing tumor-associated biomarkers.

Statera Biopharma

Market Cap: US$14.5k

Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body’s immune system and restore homeostasis.

Alternaturals

Market Cap: US$862.1k

Manufactures and distributes supplements and all-natural remedies that are alternatives to prescription drugs.

GNCC Capital

Market Cap: US$174.1k

Through its subsidiary, BioCann Pharma S.A.S., produces and sells cannabis CBD pharmaceutical grade oils.

MultiCell Technologies

Market Cap: US$5.0k

A biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional cardiology and peripheral vessel applications.

Canopus BioPharma

Market Cap: US$455.1k

A pharmaceutical research company, provides pharmaceutical products and assay methods to patients suffering from infectious, cancer, and addiction diseases.

RegeneRx Biopharmaceuticals

Market Cap: US$301.0

A biopharmaceutical company, focuses on the development of therapeutic peptide, Thymosin beta 4, for tissue and organ protection, repair, and regeneration.

Bloomios

Market Cap: US$6.8k

Manufactures, markets, and distributes cannabidiol products.

Adynxx

Market Cap: US$5.0

A clinical stage biopharmaceutical company, focuses on the development and marketing of transcription factor decoy technologies for the treatment of pain and inflammatory diseases.

Pathfinder Cell Therapy

Market Cap: US$667.0

A development stage regenerative medicine company, focuses on developing novel cell-derived and related therapies for the treatment of various diseases and medical conditions characterized by organ-specific cell damage.

RxElite

Market Cap: US$116.0

Engages in the development, manufacture, and marketing of generic prescription drug products in specialty generic markets.

Ember Therapeutics

Market Cap: US$43.0

Operates as a clinical stage biopharmaceutical company.